People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Mulet, Xavier
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (10/10 displayed)
- 2022Biomimetic Metal-Organic Frameworks as Protective Scaffolds for Live-virus Encapsulation and Vaccine Stabilisation – TEM Staining Considerations.
- 2022Biomimetic Metal-Organic Frameworks as Protective Scaffolds for Live-virus Encapsulation and Vaccine Stabilisation – TEM Staining Considerations.
- 2022Underlying Polar and Nonpolar Modification MOF-Based Factors that Influence Permanent Porosity in Porous Liquidscitations
- 2021Underlying solvent-based factors that influence permanent porosity in porous liquidscitations
- 2019Encapsulation, Visualization and Expression of Genes with Biomimetically Mineralized Zeolitic Imidazolate Framework-8 (ZIF-8)citations
- 2017Limitations with solvent exchange methods for synthesis of colloidalfullerenescitations
- 2013Predicting properties of nanoparticles for drug delivery and tissue targeting
- 2012Predicting phase behaviour of nanostructured lipid-based self-assembled materials
- 2012Predicting complex phase behaviour of self-assembling drug delivery nanoparticles
- 2011Robust and predictive modelling of amphiphilic nanostructured nanoparticle drug delivery vehicle phase behaviour
Places of action
Organizations | Location | People |
---|
document
Predicting complex phase behaviour of self-assembling drug delivery nanoparticles
Abstract
When lyotropic liquids are added to a polar solvent, nanocrystals form that adopt a range of morphologies including 1D lamellar structures, 2D inverse hexagonal phases and 3D inverse bicontinuous cubic phases (Fig. 1) The cubic phases in particular have great potential as delivery vehicles for drugs and imaging agents as they are biodegradable, adaptable to multiple drug sizes and types, have enhanced physical and chemical stability, and enhanced tissue and cellular uptake, properties valuable for new therapeutic or diagnostic applications. However little is known about the effect of the incorporated drug structure, properties and loadings on the structure of the resultant cubic nanophases, and predicting them considered intractable.Figure 1. Structure of the inverse-bicontinuous diamond QIID (Pn3m), gyroid QIIG (Ia3d), and primitive QIIP (Im3m) cubic phases. Computational machine learning tools have been an important molecular design in many areas such as agrochemistry, toxicology and especially pharmaceutical chemistry. We have applied this method to model novel amphiphilic lyotropic liquid crystalline self-assembly materials and to predict their nanomorphology when loaded with drugs. The data was generated using high throughput small angle x-ray scattering (SAXS) at the Australian Synchrotron1. We have developed, for the first time, robust and predictive models that explain the phase behaviour of lipid-based nanoparticles under different conditions. The machine learning methods we used included multiple linear regression and Bayesian regularised artificial neural networks2-4 that generate optimally sparse and predictive models relating structure to properties.In particular, we modelled the phase behaviour of two drug delivery carriers, phytantriol monoolein and Myverol (a commercial product of monoolein) when encapsulating ten drugs at six concentrations at two temperatures. Using state-of-the-art quantitative structure-property relationship modelling techniques, our models successfully predicted the phase formations with very useful accuracy for the first time. We have validated models by predicting the phase behaviour of these drug delivery carriers when loaded with eleven completely new drugs and verifying our predictions using SAXS synchrotron measurements. The model was able to predict a priori the existence of nanophases, or coexistence of nanophases, for new drugs with accuracies of 73-99%Figure 2. Individual phases including inverse-bicontinuous diamond QIID (Pn3m) cubic (blue), hexagonal HII (yellow) and primitive QIIP (Im3m) cubic (purple) predicted by the best BRANN models for Myverol nanoparticles loaded with drugs at 25 and 37oC. Circled samples indicate the mismatch between modelled and experimental results. These robust computational techniques show considerable promise for rationally designing soft nanoparticles for drug delivery5, and diverse classes of materials more generally6. They also provide a novel route to stabilizing membrane-bound receptors for structural biology studies.References (1) Mulet, X.; Kennedy, D. F.; Conn, C. E.; Hawley, A.; Drummond, C. J. Int. J. Pharm. 2010, 395, 290-297. (2) Burden, F.R.; Winkler, D.A. J. Med. Chem., 1999, 42(16); 3183-3187.(3) Burden, F.R.; Winkler, D.A. QSAR Comb. Sci. 2009, 28, 1092 – 1097. (4) Burden, F.R.; Winkler, D.A. QSAR Comb Sci. 2009, 28, 645-653. (5) Le, T.C.; Mulet, X.; Burden, F.R.; Winkler, D.A. Science, 2012 submitted. (6) Le, T.C.; Epa, V.C.; Burden, F.R.; Winkler, D.A. Chem. Rev. 2012 112 (5), 2889–2919.